Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The N-acetylaspartate (NAA) metabolic pathway centers on the synthesis, utilization, and degradation of NAA—a highly abundant metabolite in the brain and brown adipose tissue (BAT). This pathway is crucial for neuronal health, myelin lipid synthesis, energy metabolism, and metabolic adaptation in both neural and non-neural tissues. Key enzymes include Aspartate N-acetyltransferase (Asp-NAT; gene: NAT8L) and Aspartoacylase (ASPA). Abnormalities are linked with neurological diseases such as Canavan disease due to ASPA mutations leading to toxic accumulation of NAA. Changes in peripheral tissues like BAT may influence systemic energy balance/metabolic health—potential target for anti-obesity therapies via modulation of thermogenic capacity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-acetylaspartate Metabolic Pathway (NAA Metabolic Pathway).